Written by : Nikita Saha
December 4, 2024
The New Fund Offer (NFO) opens for subscription on December 6 and closes on December 20. The fund will reopen for continuous sale and repurchase within five business days of the allotment date.
Bajaj Finserv Mutual Fund has announced the launch of its new healthcare-focused equity scheme, the Bajaj Finserv Healthcare Fund. The fund is designed to provide long-term capital appreciation by investing in equity and equity-related securities within the pharma, healthcare, and allied sectors.
The New Fund Offer (NFO) opens for subscription on December 6 and closes on December 20. The fund will reopen for continuous sale and repurchase within five business days of the allotment date.
The scheme will be benchmarked against the BSE Healthcare Total Return Index (TRI) and managed by fund managers Nimesh Chandan, Sorbh Gupta, and Siddharth Chaudhary.
The scheme offers regular and direct plans, with growth and income distribution cum capital withdrawal (IDCW) options. The exit load structure is as follows:
1% exit load for units redeemed/switched out within three months from the allotment date.
No exit load for redemptions after three months.
The fund has a minimum application amount of Rs 500 for both lumpsum and systematic investment plan (SIP) investments, with SIP requiring a minimum of six installments.
The expense ratio (TER) permissible under Regulation 52 (6) (c) is capped at 2.25%.
The fund’s investment strategy includes:
80-100% allocation to equity and equity-related securities in the pharma, healthcare, and allied sectors.
0-20% allocation to equities outside the core sectors.
0-20% in debt and money market instruments.
0-10% in units issued by REITs and InvITs.
The fund targets investors seeking long-term wealth creation through equity investments in the healthcare and pharma sectors. It is categorized as having a “very high” risk level according to its riskometer.
Bajaj Finserv Mutual Fund believes the sector-focused strategy will attract investors looking to capitalize on the growth potential of the healthcare industry.